Attention Deficit Hyperactivity Disorder — ADA  

Attention Deficit Hyperactivity Disorder Clinical Trial

Official title: Addictions and Attention Deficit Disorder With or Without Hyperactivity

Status Not yet recruiting

Clinical Trial Summary

The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.

Clinical Trial Description

Information on the study and diagnosis of ADHD will be carried out during a medical evaluation consultation, as part of routine care.

The two research visits (inclusion and at 12 months) will be added by the research and will each include:

• A structured clinical interview with a research professional (traceability of oral consent, administration of structured interviews, collection of self-questionnaires, collection of care from the medical record)

• A neuropsychological assessment with a neuropsychologist ;

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder
• Behavior Disorders
• Hyperkinesis
• Mental Disorders

• NCT number: NCT06232226
• Study type: Interventional
• Source: Nantes University Hospital
• Contact: Clémence CABELGUEN, PH
• Phone: 33 2 40 84 61 16
• Email: clemence.cabelguen@chu-nantes.fr
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 1, 2024
• Completion date: March 1, 2026